( 3:15 PM- 4:00 PM ...)Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting,Health

Abstract Title: A comparison of Iodine-123 and Technetium-99m assays

                using dose calibrators


Authors:        D. L. Yokell(a), J. F. Kronauge, C. S. Kao and J. W.

                Babich; Development, Molecular Insight

                Pharmaceuticals, Inc., Cambridge, Massachusetts.


Reference #:    335015


Publication No.: 1835 - Scientific Poster Session


Poster Section: Instrumentation Posters


Session Info:   "Meet the Author" IV: Instrumentation & Data Analysis

                Posters

                Tuesday, June 5

                1:15 PM - 2:00 PM

                Hall E

Abstract Title: Synthesis and evaluation of a series of M(CO)3+

                (M=Tc,Re) lisinopril complexes for imaging angiotensin

                converting enzyme (ACE)


Authors:        F. J. Femia(a1), K. P. Maresca(1), S. M. Hillier(1),

                C. N. Zimmerman(1), J. L. Joyal(1), J. A. Barrett(1),

                T. Coleman(2), O. Aras(2), C. A. Foss(3),

                M. G. Pomper(3), V. Dilsizian(2), W. C. Eckelman(1)

                and J. W. Babich(1); 1. Molecular Insight

                Pharmaceuticals, Inc., Cambridge, Massachusetts;

                2. Nuclear Medicine, University of Maryland,

                Baltimore, Maryland and 3. Radiology, Johns Hopkins

                Medical Institutions, Baltimore, Maryland.


Reference #:    331898


Publication No.: 613 - Scientific Paper Session (Oral)


Session Info:   New Chemistry-Other II

                Wednesday, June 6

                9:45 AM - 11:15 AM

                Room 145A

On June 3rd, researchers at Molecular Insight also presented preclinical data on MIP-1072, a radiolabeled, small molecule molecular imaging pharmaceutical in development for diagnosis and staging of prostate cancer. MIP-1072 is designed to target
'"/>